We observed dose-dependent growth inhibition of the NRAS mutant neuroblastoma cell lines CHP-212 and SK-N-AS treated with MEK inhibitors AZD6244, MEK162 and PD0301925 (Fig 1A–1C). Here, MAP2K7 is linked to neuroblastoma.